Connection
Jordan Karlitz to Cost-Benefit Analysis
This is a "connection" page, showing publications Jordan Karlitz has written about Cost-Benefit Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.221 |
|
|
|
-
Karlitz JJ, Fendrick AM, Bhatt J, Coronado GD, Jeyakumar S, Smith NJ, Plescia M, Brooks D, Limburg P, Lieberman D. Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population. Popul Health Manag. 2022 06; 25(3):343-351.
Score: 0.140
-
Dore M, Ebner DW, Fendrick AM, Estes C, Aranda G, Coleman A, Vahdat V, Karlitz JJ, Rua T, van Hees F, Limburg PJ. Estimated cost, resource use, and health benefits of an increased use of next-generation multi-target stool DNA test for colorectal cancer screening from an integrated delivery network perspective. J Med Econ. 2026 Dec; 29(1):2228-2240.
Score: 0.049
-
Fisher DA, Karlitz JJ, Jeyakumar S, Smith N, Limburg P, Lieberman D, Fendrick AM. Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population. J Med Econ. 2021 Jan-Dec; 24(1):654-664.
Score: 0.033
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|